Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Humira in Peripheral Spondyloarthritis Without Ankylosing Spondylitis or Psoriatic Arthritis
2008-006885-27Phase 2Completed
- Sponsor
- Clinical Immunology and Rheumatology
- Start
- Nov 2008
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of adalimumab in peripheral spondyloarthritis (pSpA) and spondyloarthritis (SpA), sponsored by Clinical Immunology and Rheumatology. Primary endpoint: Patient's Global Assessment of Disease at week 12. Started Nov 2008; status: completed.
02
Drugs
03
Conditions
peripheral spondyloarthritis (pSpA)spondyloarthritis (SpA)
Beyond the preview
Go deeper on 2008-006885-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006885-27.